Literature DB >> 28516981

Botulinum toxin therapy: functional silencing of salivary disorders.

A Lovato1, D A Restivo2, G Ottaviano3, G Marioni3, R Marchese-Ragona3.   

Abstract

Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary fistulae that may have a post-traumatic or post-operative origin. BTX injections can be considered in sialoceles and salivary fistulae after the failure of or together with conservative treatments (e.g. antibiotics, pressure dressings, or serial aspirations). BTX treatment has a promising role in chronic sialadenitis. BTX therapy is highly successful in the treatment of gustatory sweating (Frey's syndrome), and could be considered the gold standard treatment for this neurological disorder. © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.

Entities:  

Keywords:  Botulinum toxin; Chronic sialadenitis; Frey’s syndrome; Salivary fistula; Sialocele

Mesh:

Substances:

Year:  2017        PMID: 28516981      PMCID: PMC5463526          DOI: 10.14639/0392-100X-1608

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  37 in total

1.  Improvement of diabetic autonomic gustatory sweating by botulinum toxin type A.

Authors:  D A Restivo; S Lanza; F Patti; S Giuffrida; R Marchese-Ragona; P Bramanti; A Palmeri
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

2.  Post-parotidectomy fistula.

Authors:  M Wax; L Tarshis
Journal:  J Otolaryngol       Date:  1991-02

3.  Endoscopic diagnosis of rhino-parotid fistula and successful treatment with botulinum toxin.

Authors:  Rosario Marchese-Ragona; Pier Francesco Galzignato; Gino Marioni; Luca Guarda-Nardini; Alberto Tregnaghi; Domenico A Restivo; Alberto Staffieri
Journal:  Laryngoscope       Date:  2005-11       Impact factor: 3.325

4.  Nonsurgical management of traumatic injuries of the parotid gland and duct using type a botulinum toxin.

Authors:  Sébastien Arnaud; Dominique Batifol; Patrick Goudot; Jacques Yachouh
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

5.  Treatment of iatrogenic submandibular sialocele with botulinum toxin. Case report.

Authors:  P Capaccio; V Cuccarini; V Benicchio; D Minorati; F Spadari; F Ottaviani
Journal:  Br J Oral Maxillofac Surg       Date:  2006-04-11       Impact factor: 1.651

Review 6.  Management of the Salivary Glands and Facial Nerve in Face Transplantation.

Authors:  Russell Frautschi; Antonio Rampazzo; Steven Bernard; Risal Djohan; Francis Papay; Bahar Bassiri Gharb
Journal:  Plast Reconstr Surg       Date:  2016-06       Impact factor: 4.730

7.  Combined surgical-radiological treatment of parotid gland fistulae.

Authors:  J Schindel; H Markowicz; B Levie
Journal:  J Laryngol Otol       Date:  1968-10       Impact factor: 1.469

8.  Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment.

Authors:  Young Chang Lim; Eun Chang Choi
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-18       Impact factor: 2.503

9.  Botulinum toxin therapy: a tempting tool in the management of salivary secretory disorders.

Authors:  Pasquale Capaccio; Sara Torretta; Maurizio Osio; Davide Minorati; Francesco Ottaviani; Giuseppe Sambataro; Cristina Nascimbene; Lorenzo Pignataro
Journal:  Am J Otolaryngol       Date:  2008-06-16       Impact factor: 1.808

10.  Conservative management of post-traumatic parotid fistulae and sialoceles: a prospective study.

Authors:  R Landau; M Stewart
Journal:  Br J Surg       Date:  1985-01       Impact factor: 6.939

View more
  6 in total

1.  Botulinum toxin for chronic parotid sialadenitis: A case series and systematic review.

Authors:  Madeleine P Strohl; Chia-Fan Chang; William R Ryan; Jolie L Chang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-05-02

2.  Intraductal Salivary Gland Infusion With Botulinum Toxin.

Authors:  Adam T Schwalje; Henry T Hoffman
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-09-03

Review 3.  Botulinum toxin A is an effective therapeutic tool for the management of parotid sialocele and fistula: A systematic review.

Authors:  Shivesh Maharaj; Sheetal Mungul; Abdullah Laher
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-01-23

4.  Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A.

Authors:  Ripon Chowdhury; Dev Roy; Abhimanyu Roy
Journal:  Natl J Maxillofac Surg       Date:  2021-03-16

5.  Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.

Authors:  Domenico A Restivo; Mariangela Panebianco; Antonino Casabona; Sara Lanza; Rosario Marchese-Ragona; Francesco Patti; Stefano Masiero; Antonio Biondi; Angelo Quartarone
Journal:  Toxins (Basel)       Date:  2018-01-27       Impact factor: 4.546

Review 6.  Botulinum Neurotoxins and Cancer-A Review of the Literature.

Authors:  Shivam Om Mittal; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2020-01-05       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.